Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Inhibiting certain proteins harms hair follicle immunity and increases IL-33, affecting hair health.

Cytokine therapy is promising for treating skin conditions like vitiligo and psoriasis.

Type I interferons play a key role in the development of various skin diseases.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

IL-15 promotes hair growth and protects hair follicles.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

A parasite-derived molecule speeds up skin healing and affects immune cell behavior without increasing scarring.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

NIPP1 is important for healthy skin and could help treat skin inflammation.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

RXRα is crucial for proper immune response and links diet to immune function.

Some treatments that modify the immune system might help with certain types of hair loss but haven't been explored for common hair loss alone.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

IL-27 can prevent hair loss in alopecia areata.

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Different γδ T cell types have unique roles in causing alopecia areata.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Hair loss from immunosuppressive drugs in transplant patients can affect well-being and treatment adherence, so personalized management is important.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

TLR3 activation helps improve skin and hair follicle healing in mice.